Mark Keibler

Scientist, Research & Development at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Mark Keibler's Colleagues at Alnylam Pharmaceuticals
Chelsea Tyler

Patient Services Operations Specialist

Contact Chelsea Tyler

Matt White

Director, Biostatistics

Contact Matt White

Mike Goodwin

Senior Facilities Manager

Contact Mike Goodwin

Joseph Costa

Senior Facilities Technician

Contact Joseph Costa

Jit Sheth

Medical Science Liaison

Contact Jit Sheth

Alexander Eaton

Senior Associate Scientist

Contact Alexander Eaton

View All Mark Keibler's Colleagues
Mark Keibler's Contact Details
HQ
(617) 551-8200
Location
Greater Boston
Company
Alnylam Pharmaceuticals
Mark Keibler's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Mark Keibler
Mark Keibler currently works for Alnylam Pharmaceuticals.
Mark Keibler's role at Alnylam Pharmaceuticals is Scientist, Research & Development.
Mark Keibler's email address is ***@alnylam.com. To view Mark Keibler's full email address, please signup to ConnectPlex.
Mark Keibler works in the SaaS industry.
Mark Keibler's colleagues at Alnylam Pharmaceuticals are Chelsea Tyler, Matt White, Mitchell Menard, Mike Goodwin, Joseph Costa, Jit Sheth, Alexander Eaton and others.
Mark Keibler's phone number is (617) 551-8200
See more information about Mark Keibler